Wolfgang Singer

Credentials: · · · ·

History

Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $6.1M · Mayo Clinic Rochester
2015–2027
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial of Intrathecally Administered Autologous Mesenchymal Stem Cells in Multiple System Atrophy
Food and Drug Administration · R01
Contact PI · $3.2M · Mayo Clinic Rochester
2021–2026
Differential Approach to the Postural Tachycardia Syndrome
National Institute of Neurological Disorders and Stroke · K23
Contact PI · $872.2K · Mayo Clinic Rochester
2012–2017

Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
Principal investigator · Active not recruiting · Phase 2
Mayo Clinic
2021–2026
Data Collection - Of Syncope Tilt Table Testing Study
Principal investigator · Completed
Boston Scientific Corporation
2019–2023
Mesenchymal Stem Cell Therapy in Multiple System Atrophy
Principal investigator · Active not recruiting · Phase 1, Phase 2
Mayo Clinic
2012–2027
Droxidopa / Pyridostigmine in Orthostatic Hypotension
Principal investigator · Enrolling by invitation · Phase 2
Mayo Clinic
2011–2027